On the stock market since 2021, it operates in the world of money and finance. It has 540 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 51% a year over the last 4 years. Red columns mark years that ended in a loss.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
Sales are growing strongly for its sector.
The stock has been running stronger than the market lately.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
An investor who bought at the very peak is down 81% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 58% a year on average.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
The stock trades 13% above the average analyst price target.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 2/100.
No clear buy-side message is coming from the executive floor.
On our five-subject report card, HIPO sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: HIPO is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.